The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients
Tarih
2021Yazar
Karadag, S. G.
Ozdel, S.
Yener, G. Otar
Demir, F.
Ozturk, K.
Cakan, M.
Ayaz, N. Aktay
Baglan, E.
Sozeri, B.
Sonmez, H. E.
Üst veri
Tüm öğe kaydını gösterÖzet
Objective. To determine the feasibility of withdrawing canakinumab (CAN) in a large cohort of paediatric patients with colchicine-resistant familial Mediterranean fever (crFMF).
Koleksiyonlar
- Makale [92796]